Study Shows Annual Mammography No More Effective for Older Survivors

Routine surveillance mammograms for older women with a history of breast cancer remain standard medical practice despite a lack of supporting data. A study published in JAMA Internal Medicine shows that advanced second breast cancers are no less common among women who keep up annual imaging than among those screened less often.

Annual Mammography Defaults in Aging Patients

Surviving breast cancer usually leads to a lifetime of annual imaging tests. Medical guidelines suggest older survivors continue regular mammograms indefinitely, but the practice lacks solid evidence.

“There are no data to support how we manage imaging in older breast cancer survivors,” explained Rachel Freedman, who founded and serves as the medical director of the Program for Older Adults with Breast Cancer at Dana-Farber Cancer Institute in Boston. “Because of this, the default is annual mammography like we do in younger women.”

Second Primary Cancer Rates in Older Survivors

A new study in JAMA Internal Medicine examined 9888 women with an average age of 81 who were more than 5 years past a nonmetastatic breast cancer diagnosis. Advanced second primary breast cancers proved rare in this group.

Patients who kept up annual mammography faced the same rate of advanced second primary cancers as women who were screened less often. The findings add to emerging data suggesting surveillance decisions need to be individualized. Women-centered care weighs the burdens of continued testing against a patient’s life expectancy and personal preferences.

After Breast Cancer, Mammograms Every Year Forever? What 9,888 Older Women Showed — WeTrials

Mammography Reduces Breast Cancer Mortality but Faces Age Constraints

Mammography reduces breast cancer mortality by about 20%. Nonetheless, a minimum of 10 years must pass for screening to prevent a single breast cancer death among every 1000 women examined.

Older adults often lack that timeframe and face more threatening medical conditions.

No clinical trial has specifically studied surveillance mammography in women aged 75 years or older.

“That’s sadly true for many things in medicine,” said Louise Walter, chief of the Division of Geriatrics at University of California, San Francisco.

Screening Causes Pain and Distracts from Urgent Medical Issues

Mammograms can lead to further interventions with significant risks. A study involving 216 nursing-home-eligible women with an average age of 81 found that 38 patients had abnormal mammograms requiring follow-up.

Four women received breast cancer diagnoses, and two died of other causes. In total, 42% of the participants experienced pain or psychological distress from the screening process.

Focusing on mammograms in older populations with conditions like dementia or heart failure can detract from more urgent medical issues. “The focus should have been on their current illnesses and how to help them live better,” said Louise Walter, chief of the Division of Geriatrics at University of California, San Francisco.

“To me, a mammogram is not just a flu shot,” said Louise Walter, chief of the Division of Geriatrics at University of California, San Francisco.

Conflicting Guidelines Create Clinical Challenges

Providers follow multiple guidelines when deciding whether to continue imaging. The American Cancer Society recommends annual surveillance mammograms, while the American Society of Clinical Oncology updated its approach to a risk-based model in July, suggesting screening every 1 to 2 years for low-risk tumors after year 3.

Most primary care physicians rely on US Preventive Services Task Force guidelines, which are built for the general population and suggest insufficient evidence for screening after age 75.

General guidelines often omit carveouts for life expectancy or comorbidities.

In response, the International Society of Geriatric Oncology released specific guidelines in 2021 recommending stopping screening when life expectancy drops below 5 years. The National Comprehensive Cancer Network also advocates for individualized surveillance, though providers often need a login to access those specific recommendations.

Frequently Asked Questions About Screening Older Survivors

Do older breast cancer survivors have a higher risk of recurrence?

The risk for recurrence is highest within the first 5 years after diagnosis, and patients past that timeframe face a risk that likely mirrors the general older population, according to Freedman.

What tools help physicians estimate patient life expectancy?

Physicians can utilize clinical tools such as ePrognosis and DecideTogether.info alongside their assessment of existing comorbidities like heart failure or dementia.

How do current guidelines address patient preferences?

Specialists emphasize that if an older woman wants to continue screening, she can and should after having a thorough discussion with her healthcare provider rather than following a default reflex.